Product Information
LEVONOR-E ESTRAD 0.1-0.02-0.01 is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2395 per EA under NDC 00378728490. Its NADAC has been published 502 times since Jan 11, 2017.
FDA first approved this application on Jun 17, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
LEVONOR-E ESTRAD 0.1-0.02-0.01
Levonorgestrel and Ethinyl Estradiol and Ethinyl EstradiolManufacturer
Mylan Pharmaceuticals Inc.NDC
00378728490
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA200493FDA Approved
6/17/2015
TE Code
AB
On Market Since
11/7/2016
Price Statistics
The NADAC for LEVONOR-E ESTRAD 0.1-0.02-0.01 has been published 502 times since Jan 11, 2017, and over the history we have for it it has declined 85.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2395 per EA |
|---|---|
| All-time high | $1.7117 (Feb 15, 2017) |
| All-time low | $0.1337 (Jul 17, 2024) |
| 52-week high | $0.2436 |
| 52-week low | $0.1911 |
| Median price | $0.3241 |
| Average price | $0.5746 |
| Largest weekly change | +86.4% (Nov 22, 2023) |
| Weeks tracked | 502 |
| Tracking since | Jan 11, 2017 |
1W
N/A
1M
N/A
3M
-1.7%
6M
+5.0%
1Y
+11.5%
3Y
+13.0%
5Y
-22.8%
All
-85.8%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVONOR-E ESTRAD 0.1-0.02-0.01?
The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-E ESTRAD 0.1-0.02-0.01, manufactured by Mylan Pharmaceuticals Inc., is $0.2395 per EA (NDC 00378728490), effective Aug 19, 2026.
How has the price of LEVONOR-E ESTRAD 0.1-0.02-0.01 changed over time?
Over the history we have for it, the NADAC for LEVONOR-E ESTRAD 0.1-0.02-0.01 has declined 85.8%. It has been tracked across 502 weekly CMS publications since Jan 11, 2017.
What are the highest and lowest recorded NADAC prices for LEVONOR-E ESTRAD 0.1-0.02-0.01?
Since Jan 11, 2017, the NADAC for LEVONOR-E ESTRAD 0.1-0.02-0.01 has ranged from a low of $0.1337 (Jul 17, 2024) to a high of $1.7117 (Feb 15, 2017), with a median of $0.3241 per EA.
Are there cheaper alternatives to LEVONOR-E ESTRAD 0.1-0.02-0.01?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMPESSE 0.15-0.03-0.01 MG TAB, is $0.1248 per EA — about 48% below LEVONOR-E ESTRAD 0.1-0.02-0.01.
Who manufactures LEVONOR-E ESTRAD 0.1-0.02-0.01?
LEVONOR-E ESTRAD 0.1-0.02-0.01 (NDC 00378728490) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.